Work

A Phase I/II Study of LY900003, an Antisense Inhibitor of Protein Kinase C-α, in Combination with Cisplatin and Gemcitabine in Patients with Advanced Non–Small Cell Lung Cancer

Year: 2004

Type: article

Study design: Clinical Trial

Source: Clinical Cancer Research

DOI: 10.1158/1078-0432.ccr-04-0779

Authors: Miguel A. Villalona-Calero, Paul Ritch, Jose A. Figueroa, Gregory A. Otterson, Robert Belt, Edward Dow, Sebastian George, James Leonardo, Spence McCachren, G. Lance Miller, Manuel Modiano, Manuel Valdivieso, Richard Geary, Jennifer W. Oliver, Jon Holmlund

Institutions: The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University Wexner Medical Center, Medical College of Wisconsin, East Carolina University, Thompson Cancer Survival Center, Tulsa Public Schools, The University of Texas Southwestern Medical Center, Ionis Pharmaceuticals (United States)

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2161599977

FWCI: 6.072

Cites: 36

Cited by: 87

Related to: 10